LISATA THERAPEUTICS, INC. (LSTA) Form 8-K — Jun 9, 2026
Lisata Therapeutics (LSTA) and acquirer Kuva Labs have amended their merger agreement to delay the start of the tender offer from June 1 to June 10, 2026, and extend the outside date to July 17, 2026. The acquirer currently lacks committed financing for the deal, relying instead on a non-binding indication of interest for up to $25 million from JBA Asset Management and other anticipated capital raises.
Key figures
- Extension Fee
- 1500000
- Missed Payment
- 250000
- Interim Payment1
- 150000
- Interim Payment2
- 100000
- Anticipated Financing
- 25000000
- Outside Date
- 2026-07-17
- Tender Offer Start
- 2026-06-10
- Extended Outside Date
- 2026-08-17
Price after filing
1 day: 0.0%7 days: +0.9%30 days: -7.2%
Close on the filing date to close N calendar days later (from $3.46). Historical, not a forecast.
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.